[go: up one dir, main page]

ZA200203876B - Phosphorylation of terminal primary alcohol groups. - Google Patents

Phosphorylation of terminal primary alcohol groups.

Info

Publication number
ZA200203876B
ZA200203876B ZA200203876A ZA200203876A ZA200203876B ZA 200203876 B ZA200203876 B ZA 200203876B ZA 200203876 A ZA200203876 A ZA 200203876A ZA 200203876 A ZA200203876 A ZA 200203876A ZA 200203876 B ZA200203876 B ZA 200203876B
Authority
ZA
South Africa
Prior art keywords
phosphorylation
primary alcohol
alcohol groups
terminal primary
terminal
Prior art date
Application number
ZA200203876A
Other languages
English (en)
Inventor
Michael Barry Gravestock
Kenneth Edwin Herbert Warren
David Simon Ennis
Angela Charlotte Currie
Debra Ainge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200203876B publication Critical patent/ZA200203876B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200203876A 1999-12-03 2002-05-15 Phosphorylation of terminal primary alcohol groups. ZA200203876B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates

Publications (1)

Publication Number Publication Date
ZA200203876B true ZA200203876B (en) 2003-08-15

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203876A ZA200203876B (en) 1999-12-03 2002-05-15 Phosphorylation of terminal primary alcohol groups.

Country Status (22)

Country Link
EP (1) EP1237895A2 (xx)
JP (1) JP2003515539A (xx)
KR (1) KR20020058072A (xx)
CN (1) CN1433421A (xx)
AR (1) AR026700A1 (xx)
AU (1) AU762241B2 (xx)
BG (1) BG106728A (xx)
BR (1) BR0016087A (xx)
CA (1) CA2395052A1 (xx)
CO (1) CO5271712A1 (xx)
CZ (1) CZ20021912A3 (xx)
EE (1) EE200200282A (xx)
GB (1) GB9928499D0 (xx)
HU (1) HUP0204052A2 (xx)
IL (1) IL149641A0 (xx)
IS (1) IS6401A (xx)
MX (1) MXPA02005396A (xx)
NO (1) NO20022605L (xx)
PL (1) PL364762A1 (xx)
SK (1) SK7862002A3 (xx)
WO (1) WO2001040236A2 (xx)
ZA (1) ZA200203876B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
IL160739A0 (en) 2001-09-11 2004-08-31 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
RU2004129276A (ru) 2002-02-28 2005-06-10 Астразенека Аб (Se) Производные 3-циклического-5-(азотсодержащего 5-членного кольцевого) метил-оксазолидинона и их применение в качестве антибактериальных средств
AU2003209994A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
JP2005537301A (ja) 2002-08-12 2005-12-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー N−アリール−2−オキサゾリジノン類及びそれらの誘導体
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
MXPA05005472A (es) 2002-11-21 2005-07-25 Pharmacia & Upjohn Co Llc Derivados de n-(4-piparazin-1-il)-fenil-2-oxazolidinona-5-carboxamida y compuestos relacionados como agentes antibacterianos.
PT1656370E (pt) 2003-06-03 2012-11-29 Rib X Pharmaceuticals Inc Compostos biaril-heterocíclicos e métodos de os produzir e de os utilizar
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP1904489B1 (en) 2005-06-08 2011-01-26 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
EP2069339B1 (en) 2006-09-25 2011-05-18 Wockhardt Research Centre Substituted piperidinophenyl oxazolidinones
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753988B2 (en) * 1998-06-05 2002-10-31 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
MXPA02005396A (es) 2002-11-29
WO2001040236A2 (en) 2001-06-07
PL364762A1 (en) 2004-12-13
EP1237895A2 (en) 2002-09-11
CA2395052A1 (en) 2001-06-07
EE200200282A (et) 2003-06-16
KR20020058072A (ko) 2002-07-12
CO5271712A1 (es) 2003-04-30
WO2001040236A3 (en) 2002-05-10
JP2003515539A (ja) 2003-05-07
GB9928499D0 (en) 2000-02-02
IL149641A0 (en) 2002-11-10
HUP0204052A2 (hu) 2003-03-28
IS6401A (is) 2002-05-28
SK7862002A3 (en) 2003-02-04
CZ20021912A3 (cs) 2002-08-14
CN1433421A (zh) 2003-07-30
AU762241B2 (en) 2003-06-19
AU1715601A (en) 2001-06-12
NO20022605L (no) 2002-06-26
BR0016087A (pt) 2002-08-06
NO20022605D0 (no) 2002-05-31
BG106728A (en) 2003-02-28
AR026700A1 (es) 2003-02-26

Similar Documents

Publication Publication Date Title
ZA200203876B (en) Phosphorylation of terminal primary alcohol groups.
AU2001249239A1 (en) Shared groups rostering system
AU4355500A (en) Determining the physical structure of subscriber lines
ZA200201518B (en) Dispersion formulations containing lipase inhibitors.
AU4175200A (en) Assignment
AU6181000A (en) Novel genes encoding protein kinase/protein phosphatase
AU2001283870A1 (en) Telecommunications systems
AU6180900A (en) Novel genes encoding protein kinase/protein phosphatase
AU2397500A (en) Terminal configuration
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU7460800A (en) Grounding terminal
TW482339U (en) Low crosstalk connector
AU6355700A (en) Dsp-11 dual-specificity map kinase phosphatase
AU2001262823A1 (en) System protection scheme
AU4658400A (en) Dsp-10 dual-specificity map kinsase phosphatase
AU2135801A (en) Network-based talk show system
GB0128847D0 (en) Monolithic capacitor array & electrical connector
GB0118868D0 (en) Insulator
HK1049009A (en) Phosphorylation of terminal primary alcohol groups
AU1283801A (en) Neurological plug
AU2000279108A1 (en) Opimization of service access
AU2002222660A1 (en) Pre-listed share circulation system
AU4213100A (en) Dsp-4 dual-specificity map kinase phosphatase
AU4206700A (en) Dsp-3 dual-specificity phosphatase
AU2569200A (en) High isolation couplers